Abbott is a global leader in point-of-care (POC) diagnostics with a comprehensive portfolio of rapid tests, services, and handheld devices for use in a wide variety of healthcare settings: labs, clinics, remote healthcare outposts, retail outlets, the patient’s bedside and at home. Abbott’s offering of near-patient tests and services spans key health and therapeutic areas, including infectious disease, cardiometabolic, informatics, toxicology and consumer diagnostics.

AG Health

AGHealth is a small, UK-based company, specialising in leading obstetric, gynaecology and neonatal products. We are committed to improving the secondary care experience for both clinicians and patients, and we pride ourselves on our clinical knowledge combined with excellent customer service, offering clinical support and advice to ensure the best possible outcomes. 

Essity UK

Essity UK is a passionate, complete personal care solutions provider that offers innovative products, award winning education, and aligned services. We  strive to develop valued partnerships with our clinical & non-clinical customers and with patients to improve their health outcomes and support the drive for efficiencies and reduce wastage across the entire UK health economy.  We can achieve this by going – Forward. Together. Visit us at our stand to find out more about how Leukomed Sorbact can help to prevent SSI in C-Section surgery – recently awarded NICE Medical Technologies Guidance 55.

GE Healthcare

At GE HealthCare, we see possibilities through innovation. We’re dedicated to providing integrated solutions that make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier. Together, we’re creating a world where healthcare has no limits. Learn more at www.gehealthcare.com.


Hologic are an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. Our purpose is to enable healthier lives everywhere, every day.

Hologic’s quantitative Rapid fFN Test on the PeriLynx System is a tool available to help healthcare professionals understand the true risk of preterm labour for pregnant women exhibiting signs & symptoms, or at high-risk of preterm birth. This information can be used with other clinical insight to help manage care and determine treatment choices for patients. Visit www.ffntest.co.uk

Jackson Lees Group 

Jackson Lees Group are an award-winning, full-service law firm in Liverpool and the North West committed to doing what is right. We truly value the unique and longstanding relationships we have forged with our clients.

Our Medical Negligence team has over 25 years’ experience in a wide range of cases including perinatal injury resulting in life-long disabilities and still birth.  We also represent families at Inquests.   

We are independently accredited by the patient safety charity, Action Against Medical Accidents (AvMA).

L.D. Collins 

Specializing in women’s reproductive health, L.D. Collins is a pioneering British company and proud home of Cyclogest®. Our commitment to excellence is evident in our status as a world leader in progesterone products.

Cyclogest® has earned its place in over 60 countries, tried and trusted by clinical experts worldwide as the ‘Gold Standard’ in micronized vaginal progesterone. It stands as the preferred choice for luteal phase support.

Our unwavering dedication to women’s well-being is showcased through our close collaborations with esteemed medical professionals and international partners, ensuring the highest levels of quality and service on a global scale.


Pregnolia AG is a Women’s Health startup based in Switzerland, developing a medical device to support the risk assessment of premature birth. The Pregnolia System is the first CE-marked medical device to accurately measure cervical stiffness – it is based on the aspiration technique and measurements can be done in a simple, safe and quick way. 

Pregnolia wants to help clinicians provide a more informed care by better revealing the biomechanical status of the cervix at different moments of the pregnancy, improving on the current standard for risk stratification.